Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself
Despite extensive efforts, neurodegenerative diseases (ND) continue to feel like a pharmaceutical frontier. We have…
Products
3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs
A caveat to a successful pharmaceutical industry in which many effective drugs have already been…
How Amgen looks at stability characterization to boost the success of biologics candidates
Biologic drugs have been incredibly successful in terms of both medical achievement and profitability. Many…
The NanoTemper Story – Chapter 6: The Prometheus Panta
Take a moment to consider what it would have been like to be a researcher…
Characterize the true nature of intrinsically disordered proteins without immobilizing them
If you study neurodegenerative diseases (ND), you already know they are one of the most…
NanoTemper Technologies launches DLS capability with Prometheus Panta, bringing high-resolution, domain-specific stability characterization to biologics
Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations
NanoTemper debuts the newly redesigned Monolith, offering higher-quality molecular interaction measurements for very challenging targets
PRESS RELEASE South San Francisco, CA. NanoTemper Technologies, well-known for creating biophysical tools that address…
How to confirm you’ve cooked perfect eggs, using scientific instruments
If you’ve been following my cooking and chemistry blog series, I hope you’ve enjoyed recaps…
The NanoTemper Story – Chapter 5: The Dianthus
Almost as soon as the Monolith launched, the handful of people that made up NanoTemper…